EWING, N.J., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that Scott Jackson, Chief Executive Officer, will now present an overview of the company at the 16th Annual BIO CEO and Investor Conference on Monday, February 10, 2014, at 9:00 a.m. EST. The conference is being held at the Waldorf Astoria in New York.
Help employers find you! Check out all the jobs and post your resume.
